ArticleJournal of translational autoimmunity2025

Targeted regulatory T cell activation by site-specific PEGylated interleukin-2 mitigates autoimmune inflammation.

Masahiro Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.